Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2

Abstract Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and AI-driven drug discovery. Digital twins, as dy...

Full description

Saved in:
Bibliographic Details
Main Authors: Igor Petrušić, Chia-Chun Chiang, David Garcia-Azorin, Woo-Seok Ha, Raffaele Ornello, Lanfranco Pellesi, Eloisa Rubio-Beltrán, Ruth Ruscheweyh, Marta Waliszewska-Prosół, William Wells-Gatnik
Format: Article
Language:English
Published: BMC 2025-01-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:https://doi.org/10.1186/s10194-024-01944-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559231128403968
author Igor Petrušić
Chia-Chun Chiang
David Garcia-Azorin
Woo-Seok Ha
Raffaele Ornello
Lanfranco Pellesi
Eloisa Rubio-Beltrán
Ruth Ruscheweyh
Marta Waliszewska-Prosół
William Wells-Gatnik
author_facet Igor Petrušić
Chia-Chun Chiang
David Garcia-Azorin
Woo-Seok Ha
Raffaele Ornello
Lanfranco Pellesi
Eloisa Rubio-Beltrán
Ruth Ruscheweyh
Marta Waliszewska-Prosół
William Wells-Gatnik
author_sort Igor Petrušić
collection DOAJ
description Abstract Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and AI-driven drug discovery. Digital twins, as dynamic digital representations of patients, offer opportunities for personalized headache management by integrating diverse datasets such as neuroimaging, multiomics, and wearable sensor data to advance headache research, optimize treatment, and enable virtual trials. In addition, AI-driven wearable devices equipped with next-generation biosensors combined with multi-agent chatbots could enable real-time physiological and biochemical monitoring, diagnosing, facilitating early headache attack forecasting and prevention, disease tracking, and personalized interventions. Furthermore, AI-driven advances in drug discovery leverage machine learning and generative AI to accelerate the identification of novel therapeutic targets and optimize treatment strategies for migraine and other headache disorders. Despite these advances, challenges such as data standardization, model explainability, and ethical considerations remain pivotal. Collaborative efforts between clinicians, biomedical and biotechnological engineers, AI scientists, legal representatives and bioethics experts are essential to overcoming these barriers and unlocking AI’s full potential in transforming headache research and healthcare. This is a call to action in proposing novel frameworks for integrating AI-based technologies into headache care. Graphical Abstract
format Article
id doaj-art-a16f11eeccd340799351df8ec49bf6ab
institution Kabale University
issn 1129-2377
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj-art-a16f11eeccd340799351df8ec49bf6ab2025-01-05T12:41:49ZengBMCThe Journal of Headache and Pain1129-23772025-01-0126111310.1186/s10194-024-01944-7Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2Igor Petrušić0Chia-Chun Chiang1David Garcia-Azorin2Woo-Seok Ha3Raffaele Ornello4Lanfranco Pellesi5Eloisa Rubio-Beltrán6Ruth Ruscheweyh7Marta Waliszewska-Prosół8William Wells-Gatnik9Laboratory for Advanced Analysis of Neuroimages, Faculty of Physical Chemistry, University of BelgradeDepartment of Neurology, Mayo ClinicDepartment of Medicine, Toxicology and Dermatology, Faculty of Medicine, University of ValladolidDepartment of Neurology, Severance Hospital, Yonsei University College of MedicineDepartment of Biotechnological and Applied Clinical Sciences, University of L’AquilaClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern DenmarkHeadache Group. Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College LondonDepartment of Neurology, LMU University Hospital, LMU MunichDepartment of Neurology, Wrocław Medical UniversityUnitelma Sapienza University of RomeAbstract Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and AI-driven drug discovery. Digital twins, as dynamic digital representations of patients, offer opportunities for personalized headache management by integrating diverse datasets such as neuroimaging, multiomics, and wearable sensor data to advance headache research, optimize treatment, and enable virtual trials. In addition, AI-driven wearable devices equipped with next-generation biosensors combined with multi-agent chatbots could enable real-time physiological and biochemical monitoring, diagnosing, facilitating early headache attack forecasting and prevention, disease tracking, and personalized interventions. Furthermore, AI-driven advances in drug discovery leverage machine learning and generative AI to accelerate the identification of novel therapeutic targets and optimize treatment strategies for migraine and other headache disorders. Despite these advances, challenges such as data standardization, model explainability, and ethical considerations remain pivotal. Collaborative efforts between clinicians, biomedical and biotechnological engineers, AI scientists, legal representatives and bioethics experts are essential to overcoming these barriers and unlocking AI’s full potential in transforming headache research and healthcare. This is a call to action in proposing novel frameworks for integrating AI-based technologies into headache care. Graphical Abstracthttps://doi.org/10.1186/s10194-024-01944-7Digital twinBiosensorsWearable devicesDrug discoveryMigraineMachine learning
spellingShingle Igor Petrušić
Chia-Chun Chiang
David Garcia-Azorin
Woo-Seok Ha
Raffaele Ornello
Lanfranco Pellesi
Eloisa Rubio-Beltrán
Ruth Ruscheweyh
Marta Waliszewska-Prosół
William Wells-Gatnik
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
The Journal of Headache and Pain
Digital twin
Biosensors
Wearable devices
Drug discovery
Migraine
Machine learning
title Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
title_full Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
title_fullStr Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
title_full_unstemmed Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
title_short Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
title_sort influence of next generation artificial intelligence on headache research diagnosis and treatment the junior editorial board members vision part 2
topic Digital twin
Biosensors
Wearable devices
Drug discovery
Migraine
Machine learning
url https://doi.org/10.1186/s10194-024-01944-7
work_keys_str_mv AT igorpetrusic influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT chiachunchiang influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT davidgarciaazorin influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT wooseokha influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT raffaeleornello influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT lanfrancopellesi influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT eloisarubiobeltran influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT ruthruscheweyh influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT martawaliszewskaprosoł influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2
AT williamwellsgatnik influenceofnextgenerationartificialintelligenceonheadacheresearchdiagnosisandtreatmentthejunioreditorialboardmembersvisionpart2